You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API olopatadine hydrochloride ophthalmic solution

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing olopatadine hydrochloride ophthalmic solution

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC	Excipient
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689	BENZALKONIUM CHLORIDE
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689	HYDROCHLORIC ACID
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689	SODIUM CHLORIDE
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689	SODIUM HYDROXIDE
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689	SODIUM PHOSPHATE, DIBASIC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689	WATER
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for olopatadine hydrochloride ophthalmic solution

Excipient focus: BENZALKONIUM CHLORIDE

olopatadine hydrochloride ophthalmic solution drug variants containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: EDETATE DISODIUM

olopatadine hydrochloride ophthalmic solution drug variants containing EDETATE DISODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing EDETATE DISODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

olopatadine hydrochloride ophthalmic solution drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE

olopatadine hydrochloride ophthalmic solution drug variants containing POVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing POVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE K30

olopatadine hydrochloride ophthalmic solution drug variants containing POVIDONE K30

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing POVIDONE K30

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

olopatadine hydrochloride ophthalmic solution drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

olopatadine hydrochloride ophthalmic solution drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC

olopatadine hydrochloride ophthalmic solution drug variants containing SODIUM PHOSPHATE, DIBASIC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing SODIUM PHOSPHATE, DIBASIC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

olopatadine hydrochloride ophthalmic solution drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

Excipient focus: WATER

olopatadine hydrochloride ophthalmic solution drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Target Corporation	olopatadine hydrochloride ophthalmic solution	11673-689
H E B	olopatadine hydrochloride ophthalmic solution	37808-045
>Company	>Ingredient	>NDC

olopatadine hydrochloride ophthalmic solution drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Cipla USA Inc	olopatadine hydrochloride ophthalmic solution	69097-276
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.